Click here to get full coverage on $DTIL stock is down 9% today. Here's what we see in our data. - Quiver Quantitative

$DTIL stock is down 9% today. Here's what we see in our data.  Quiver Quantitative

$DTIL stock is down 9% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on DTIL Stock Price, Quote & Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill

DTIL Stock Price, Quote & Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL)  ChartMill

DTIL Stock Price, Quote & Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill

Click here to get full coverage on Precision BioSciences, Inc. (DTIL) Discusses Updates on PBG and HBV Program and ELIMINATE-B Trial Results - Slideshow (NASDAQ:DTIL) 2026-05-27 - Seeking Alpha

Precision BioSciences, Inc. (DTIL) Discusses Updates on PBG and HBV Program and ELIMINATE-B Trial Results - Slideshow (NASDAQ:DTIL) 2026-05-27  Seeking Alpha

Precision BioSciences, Inc. (DTIL) Discusses Updates on PBG and HBV Program and ELIMINATE-B Trial Results - Slideshow (NASDAQ:DTIL) 2026-05-27 - Seeking Alpha

Click here to get full coverage on Precision BioSciences (DTIL) shareholders approve 3.8M-share incentive plan increase and officer exculpation - Stock Titan

Precision BioSciences (DTIL) shareholders approve 3.8M-share incentive plan increase and officer exculpation  Stock Titan

Precision BioSciences (DTIL) shareholders approve 3.8M-share incentive plan increase and officer exculpation - Stock Titan

Click here to get full coverage on Guggenheim Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $19 - Moomoo

Guggenheim Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $19  Moomoo

Guggenheim Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $19 - Moomoo

Click here to get full coverage on Precision BioSciences (DTIL) Unveils Groundbreaking Data on PBGE - GuruFocus

Precision BioSciences (DTIL) Unveils Groundbreaking Data on PBGE  GuruFocus

Precision BioSciences (DTIL) Unveils Groundbreaking Data on PBGE - GuruFocus

Click here to get full coverage on Precision BioSciences (DTIL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Precision BioSciences (DTIL) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance

Precision BioSciences (DTIL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on Why Is Precision BioSciences Stock Gaining Wednesday? - Precision BioSciences (NASDAQ:DTIL) - Benzinga

Why Is Precision BioSciences Stock Gaining Wednesday? - Precision BioSciences (NASDAQ:DTIL)  Benzinga

Why Is Precision BioSciences Stock Gaining Wednesday? - Precision BioSciences (NASDAQ:DTIL) - Benzinga

Click here to get full coverage on Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026 - Business Wire

Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026  Business Wire

Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026 - Business Wire

Click here to get full coverage on Analysts Conflicted on These Healthcare Names: MannKind (MNKD), Biohaven Ltd. (BHVN) and Precision BioSciences (DTIL) - The Globe and Mail

Analysts Conflicted on These Healthcare Names: MannKind (MNKD), Biohaven Ltd. (BHVN) and Precision BioSciences (DTIL)  The Globe and Mail

Analysts Conflicted on These Healthcare Names: MannKind (MNKD), Biohaven Ltd. (BHVN) and Precision BioSciences (DTIL) - The Globe and Mail

Click here to get full coverage on DTIL Stock Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill

DTIL Stock Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL)  ChartMill

DTIL Stock Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill

Click here to get full coverage on DTIL Reiterates by HC Wainwright & Co. -- Price Target Maintained at $60 - GuruFocus

DTIL Reiterates by HC Wainwright & Co. -- Price Target Maintained at $60  GuruFocus

DTIL Reiterates by HC Wainwright & Co. -- Price Target Maintained at $60 - GuruFocus

Click here to get full coverage on New PBGENE-HBV hepatitis B data from Precision BioSciences (Nasdaq: DTIL) - Stock Titan

New PBGENE-HBV hepatitis B data from Precision BioSciences (Nasdaq: DTIL)  Stock Titan

New PBGENE-HBV hepatitis B data from Precision BioSciences (Nasdaq: DTIL) - Stock Titan

Click here to get full coverage on Precision BioSciences (DTIL) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance

Precision BioSciences (DTIL) Surpasses Q4 Earnings and Revenue Estimates  Yahoo Finance

Precision BioSciences (DTIL) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on Bullish: Analysts Just Made A Notable Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts - Yahoo Finance

Bullish: Analysts Just Made A Notable Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts  Yahoo Finance

Bullish: Analysts Just Made A Notable Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts - Yahoo Finance

Click here to get full coverage on Director Melinda Brown receives 21,000 DTIL shares as RSUs vest (DTIL) - Stock Titan

Director Melinda Brown receives 21,000 DTIL shares as RSUs vest (DTIL)  Stock Titan

Director Melinda Brown receives 21,000 DTIL shares as RSUs vest (DTIL) - Stock Titan

Click here to get full coverage on Director at Precision BioSciences (DTIL) sees 21,000 RSUs vest into common stock - Stock Titan

Director at Precision BioSciences (DTIL) sees 21,000 RSUs vest into common stock  Stock Titan

Director at Precision BioSciences (DTIL) sees 21,000 RSUs vest into common stock - Stock Titan

Click here to get full coverage on Precision Biosciences (DTIL) director gains 21,000 shares as RSUs vest into common stock - Stock Titan

Precision Biosciences (DTIL) director gains 21,000 shares as RSUs vest into common stock  Stock Titan

Precision Biosciences (DTIL) director gains 21,000 shares as RSUs vest into common stock - Stock Titan

Click here to get full coverage on Precision Biosciences (NASDAQ: DTIL) director’s 21,000 RSUs vest into shares - Stock Titan

Precision Biosciences (NASDAQ: DTIL) director’s 21,000 RSUs vest into shares  Stock Titan

Precision Biosciences (NASDAQ: DTIL) director’s 21,000 RSUs vest into shares - Stock Titan

Click here to get full coverage on Precision BioSciences (DTIL) director gains 21,000 shares from RSU vesting - Stock Titan

Precision BioSciences (DTIL) director gains 21,000 shares from RSU vesting  Stock Titan

Precision BioSciences (DTIL) director gains 21,000 shares from RSU vesting - Stock Titan

Click here to get full coverage on Gene editing for hepatitis B: Precision BioSciences to share new data - Stock Titan

Gene editing for hepatitis B: Precision BioSciences to share new data  Stock Titan

Gene editing for hepatitis B: Precision BioSciences to share new data - Stock Titan

Click here to get full coverage on Analyst Forecasts For Precision BioSciences, Inc. (NASDAQ:DTIL) Are Surging Higher - simplywall.st

Analyst Forecasts For Precision BioSciences, Inc. (NASDAQ:DTIL) Are Surging Higher  simplywall.st

Analyst Forecasts For Precision BioSciences, Inc. (NASDAQ:DTIL) Are Surging Higher - simplywall.st

Click here to get full coverage on DTIL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

DTIL Financials: Income Statement, Balance Sheet & Cash Flow  Stock Titan

DTIL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Click here to get full coverage on DTIL: Shareholders approved all proposals as the company advanced key clinical programs and strengthened its finances - TradingView

DTIL: Shareholders approved all proposals as the company advanced key clinical programs and strengthened its finances  TradingView

DTIL: Shareholders approved all proposals as the company advanced key clinical programs and strengthened its finances - TradingView

Click here to get full coverage on Precision BioSciences Put Its ARCUS Gene Editing Data Front And Center - Finimize

Precision BioSciences Put Its ARCUS Gene Editing Data Front And Center  Finimize

Precision BioSciences Put Its ARCUS Gene Editing Data Front And Center - Finimize

Click here to get full coverage on $DTIL stock is up 11% today. Here's what we see in our data. - Quiver Quantitative

$DTIL stock is up 11% today. Here's what we see in our data.  Quiver Quantitative

$DTIL stock is up 11% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Should You Buy Precision BioSciences (DTIL) After Golden Cross? - Yahoo Finance

Should You Buy Precision BioSciences (DTIL) After Golden Cross?  Yahoo Finance

Should You Buy Precision BioSciences (DTIL) After Golden Cross? - Yahoo Finance

Click here to get full coverage on FDA Fast Tracks experimental Duchenne muscular dystrophy therapy - Stock Titan

FDA Fast Tracks experimental Duchenne muscular dystrophy therapy  Stock Titan

FDA Fast Tracks experimental Duchenne muscular dystrophy therapy - Stock Titan

Click here to get full coverage on Insider Sale: President and CEO of $DTIL Sells 34,799 Shares - Quiver Quantitative

Insider Sale: President and CEO of $DTIL Sells 34,799 Shares  Quiver Quantitative

Insider Sale: President and CEO of $DTIL Sells 34,799 Shares - Quiver Quantitative

Click here to get full coverage on Precision BioSciences (DTIL) Set to Report Q1 2026 Earnings with Analyst Expectations - GuruFocus

Precision BioSciences (DTIL) Set to Report Q1 2026 Earnings with Analyst Expectations  GuruFocus

Precision BioSciences (DTIL) Set to Report Q1 2026 Earnings with Analyst Expectations - GuruFocus

Click here to get full coverage on Patent nod through 2044 backs hepatitis B gene edit program - Stock Titan

Patent nod through 2044 backs hepatitis B gene edit program  Stock Titan

Patent nod through 2044 backs hepatitis B gene edit program - Stock Titan

Click here to get full coverage on Precision BioSciences (DTIL) Q4 Profit Of US$19.2m Challenges Ongoing Loss Narrative - simplywall.st

Precision BioSciences (DTIL) Q4 Profit Of US$19.2m Challenges Ongoing Loss Narrative  simplywall.st

Precision BioSciences (DTIL) Q4 Profit Of US$19.2m Challenges Ongoing Loss Narrative - simplywall.st

Click here to get full coverage on Mouse gene edit boosts muscle protein 12x, backing DMD care from age 2 - Stock Titan

Mouse gene edit boosts muscle protein 12x, backing DMD care from age 2  Stock Titan

Mouse gene edit boosts muscle protein 12x, backing DMD care from age 2 - Stock Titan

Click here to get full coverage on A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy - simplywall.st

A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy  simplywall.st

A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy - simplywall.st

Click here to get full coverage on Experimental gene therapy cuts life-threatening ammonia crises in infants - Stock Titan

Experimental gene therapy cuts life-threatening ammonia crises in infants  Stock Titan

Experimental gene therapy cuts life-threatening ammonia crises in infants - Stock Titan

Click here to get full coverage on Newborn gene trial cuts life-threatening ammonia crises by up to 65% - Stock Titan

Newborn gene trial cuts life-threatening ammonia crises by up to 65%  Stock Titan

Newborn gene trial cuts life-threatening ammonia crises by up to 65% - Stock Titan

Click here to get full coverage on Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire

Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update  Business Wire

Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire

Click here to get full coverage on Precision Biosciences: Still Swinging And Finally Drawing Blood (NASDAQ:DTIL) - Seeking Alpha

Precision Biosciences: Still Swinging And Finally Drawing Blood (NASDAQ:DTIL)  Seeking Alpha

Precision Biosciences: Still Swinging And Finally Drawing Blood (NASDAQ:DTIL) - Seeking Alpha

Click here to get full coverage on France and Romania join Precision Bio’s hepatitis B gene-editing trial - Stock Titan

France and Romania join Precision Bio’s hepatitis B gene-editing trial  Stock Titan

France and Romania join Precision Bio’s hepatitis B gene-editing trial - Stock Titan

Click here to get full coverage on PBGENE-DMD gene editing strategy at Precision BioSciences (NASDAQ: DTIL) - Stock Titan

PBGENE-DMD gene editing strategy at Precision BioSciences (NASDAQ: DTIL)  Stock Titan

PBGENE-DMD gene editing strategy at Precision BioSciences (NASDAQ: DTIL) - Stock Titan

Click here to get full coverage on Precision BioSciences 1Q 2026: Revenue $10.8M, EPS $(0.75) — 10-Q Summary - TradingView

Precision BioSciences 1Q 2026: Revenue $10.8M, EPS $(0.75) — 10-Q Summary  TradingView

Precision BioSciences 1Q 2026: Revenue $10.8M, EPS $(0.75) — 10-Q Summary - TradingView

Click here to get full coverage on DTIL: Advanced gene editing trials and improved financials, with strong cash runway through 2028 - TradingView

DTIL: Advanced gene editing trials and improved financials, with strong cash runway through 2028  TradingView

DTIL: Advanced gene editing trials and improved financials, with strong cash runway through 2028 - TradingView

Click here to get full coverage on Empery Asset Management, Ryan M. Lane (DTIL) disclose 7.63% ownership - Stock Titan

Empery Asset Management, Ryan M. Lane (DTIL) disclose 7.63% ownership  Stock Titan

Empery Asset Management, Ryan M. Lane (DTIL) disclose 7.63% ownership - Stock Titan

Click here to get full coverage on Gene-editing trial update points to fewer crises in 7 infants - Stock Titan

Gene-editing trial update points to fewer crises in 7 infants  Stock Titan

Gene-editing trial update points to fewer crises in 7 infants - Stock Titan

Click here to get full coverage on FDA fast-tracks gene-editing treatment for infants with rare liver disorder - Stock Titan

FDA fast-tracks gene-editing treatment for infants with rare liver disorder  Stock Titan

FDA fast-tracks gene-editing treatment for infants with rare liver disorder - Stock Titan

Click here to get full coverage on FDA puts infant gene therapy ECUR-506 in rare CMC pilot to speed manufacturing talks - Stock Titan

FDA puts infant gene therapy ECUR-506 in rare CMC pilot to speed manufacturing talks  Stock Titan

FDA puts infant gene therapy ECUR-506 in rare CMC pilot to speed manufacturing talks - Stock Titan

Click here to get full coverage on Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL) - Seeking Alpha

Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL)  Seeking Alpha

Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL) - Seeking Alpha

Click here to get full coverage on First patients can now enroll in Precision Bio's Duchenne study - Stock Titan

First patients can now enroll in Precision Bio's Duchenne study  Stock Titan

First patients can now enroll in Precision Bio's Duchenne study - Stock Titan

Click here to get full coverage on Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Business Wire

Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update  Business Wire

Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Business Wire

Click here to get full coverage on Precision BioSciences to Report First Quarter 2026 Financial Results on May 5, 2026 - Yahoo Finance

Precision BioSciences to Report First Quarter 2026 Financial Results on May 5, 2026  Yahoo Finance

Precision BioSciences to Report First Quarter 2026 Financial Results on May 5, 2026 - Yahoo Finance

Click here to get full coverage on Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)  Business Wire

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Click here to get full coverage on Precision BioSciences to Report Fourth Quarter and Fiscal Year 2025 Results on March 12, 2026 - Business Wire

Precision BioSciences to Report Fourth Quarter and Fiscal Year 2025 Results on March 12, 2026  Business Wire

Precision BioSciences to Report Fourth Quarter and Fiscal Year 2025 Results on March 12, 2026 - Business Wire

Click here to get full coverage on Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference - Yahoo Finance

Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference  Yahoo Finance

Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference - Yahoo Finance

Click here to get full coverage on H.C. Wainwright Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $60 - 富途牛牛

H.C. Wainwright Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $60  富途牛牛

H.C. Wainwright Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $60 - 富途牛牛

Click here to get full coverage on Precision BioSciences stock jumps on hepatitis B trial data By Investing.com - Investing.com South Africa

Precision BioSciences stock jumps on hepatitis B trial data By Investing.com  Investing.com South Africa

Precision BioSciences stock jumps on hepatitis B trial data By Investing.com - Investing.com South Africa

Click here to get full coverage on Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries - Business Wire

Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries  Business Wire

Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries - Business Wire

Click here to get full coverage on Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting - Business Wire

Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting  Business Wire

Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting - Business Wire

Click here to get full coverage on Precision Bio Q1 sales beat, helped by milestone revenue - TradingView

Precision Bio Q1 sales beat, helped by milestone revenue  TradingView

Precision Bio Q1 sales beat, helped by milestone revenue - TradingView

Click here to get full coverage on Precision BioSciences Receives $7.5M in Proceeds from TG Therapeutics for Azer-cel Clinical Milestone in Multiple Sclerosis - Yahoo Finance

Precision BioSciences Receives $7.5M in Proceeds from TG Therapeutics for Azer-cel Clinical Milestone in Multiple Sclerosis  Yahoo Finance

Precision BioSciences Receives $7.5M in Proceeds from TG Therapeutics for Azer-cel Clinical Milestone in Multiple Sclerosis - Yahoo Finance

Click here to get full coverage on Precision BioSciences advances gene editing programs with key milestones - Investing.com

Precision BioSciences advances gene editing programs with key milestones  Investing.com

Precision BioSciences advances gene editing programs with key milestones - Investing.com

Click here to get full coverage on Precision BioSciences stock (US74019P1084): Q3 2024 earnings report shows EPS loss - AD HOC NEWS

Precision BioSciences stock (US74019P1084): Q3 2024 earnings report shows EPS loss  AD HOC NEWS

Precision BioSciences stock (US74019P1084): Q3 2024 earnings report shows EPS loss - AD HOC NEWS

Click here to get full coverage on Precision BioSciences stock (US74019P1084): earnings miss and volatile recovery in gene editing play - AD HOC NEWS

Precision BioSciences stock (US74019P1084): earnings miss and volatile recovery in gene editing play  AD HOC NEWS

Precision BioSciences stock (US74019P1084): earnings miss and volatile recovery in gene editing play - AD HOC NEWS

Click here to get full coverage on Precision BioSciences stock (US74019P1084): gene-editing player updates clinical pipeline and strate - AD HOC NEWS

Precision BioSciences stock (US74019P1084): gene-editing player updates clinical pipeline and strate  AD HOC NEWS

Precision BioSciences stock (US74019P1084): gene-editing player updates clinical pipeline and strate - AD HOC NEWS

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Precision BioSciences stock (US74019P1084): gene-editing player in focus after fresh ECUR?506 trial - AD HOC NEWS

Precision BioSciences stock (US74019P1084): gene-editing player in focus after fresh ECUR?506 trial  AD HOC NEWS

Precision BioSciences stock (US74019P1084): gene-editing player in focus after fresh ECUR?506 trial - AD HOC NEWS

Click here to get full coverage on Precision BioSciences: Q1 Earnings Snapshot - marketscreener.com

Precision BioSciences: Q1 Earnings Snapshot  marketscreener.com

Precision BioSciences: Q1 Earnings Snapshot - marketscreener.com

Click here to get full coverage on Precision BioSciences (DTIL) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $DTIL - MarketBeat

Precision BioSciences (DTIL) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $DTIL  MarketBeat

DTIL

Price Chart

Key Statistics

Technicals

About DTIL

Latest News

$DTIL stock is down 9% today. Here's what we see in our data. - Quiver Quantitative

DTIL Stock Price, Quote & Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill

Precision BioSciences, Inc. (DTIL) Discusses Updates on PBG and HBV Program and ELIMINATE-B Trial Results - Slideshow (NASDAQ:DTIL) 2026-05-27 - Seeking Alpha

Advanced Charts

Top Gainers

Top Losers